CLINICAL TRIALS PROFILE FOR NUVARING

All Clinical Trials for NUVARING

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00269620 ↗	PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra	Completed	Magee-Womens Hospital	Phase 4	2005-06-01	This is an open-label prospective, multicenter, randomized trial to compare continuation rates into the fourth cycle of women using either the NuvaRing or OrthoEvra. Five hundred women will be recruited at 9 centers nationwide to be randomly assigned to use either the NuvaRing or OrthoEvra for four months. Women must either be on the pill or have recently stopped the pill and be relatively satisfied with oral contraceptive use to qualify for enrollment. Two visits and two phone calls will be required.
NCT00269620 ↗	PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra	Completed	Organon	Phase 4	2005-06-01	This is an open-label prospective, multicenter, randomized trial to compare continuation rates into the fourth cycle of women using either the NuvaRing or OrthoEvra. Five hundred women will be recruited at 9 centers nationwide to be randomly assigned to use either the NuvaRing or OrthoEvra for four months. Women must either be on the pill or have recently stopped the pill and be relatively satisfied with oral contraceptive use to qualify for enrollment. Two visits and two phone calls will be required.
NCT00269620 ↗	PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra	Completed	University of Pittsburgh	Phase 4	2005-06-01	This is an open-label prospective, multicenter, randomized trial to compare continuation rates into the fourth cycle of women using either the NuvaRing or OrthoEvra. Five hundred women will be recruited at 9 centers nationwide to be randomly assigned to use either the NuvaRing or OrthoEvra for four months. Women must either be on the pill or have recently stopped the pill and be relatively satisfied with oral contraceptive use to qualify for enrollment. Two visits and two phone calls will be required.
NCT00357526 ↗	Oral Contraceptive Pills Compared to Vaginal Rings	Completed	Organon	N/A	2003-04-01	The purpose of this study is to determine whether teens and young women would prefer the Nuvaring to oral contraceptive pills after having tried both methods.
NCT00357526 ↗	Oral Contraceptive Pills Compared to Vaginal Rings	Completed	University of California, San Francisco	N/A	2003-04-01	The purpose of this study is to determine whether teens and young women would prefer the Nuvaring to oral contraceptive pills after having tried both methods.

Clinical Trial Conditions for NUVARING

Condition Name

Condition Name for NUVARING
Intervention	Trials
Contraception	6
Bacterial Vaginosis	2
Infertility	2
HIV	2

Condition MeSH

Condition MeSH for NUVARING
Intervention	Trials
Vaginosis, Bacterial	3
Infertility	2
Polycystic Ovary Syndrome	2
Vaginal Diseases	2

Clinical Trial Locations for NUVARING

Trials by Country

Trials by Country for NUVARING
Location	Trials
United States	28
Kenya	2
Thailand	2
Canada	2
Peru	2

Trials by US State

Trials by US State for NUVARING
Location	Trials
Virginia	3
New York	3
Illinois	3
California	3
Pennsylvania	2

Clinical Trial Progress for NUVARING

Clinical Trial Phase

Clinical Trial Phase for NUVARING
Clinical Trial Phase	Trials
Phase 4	11
Phase 3	2
Phase 2	3

Clinical Trial Status

Clinical Trial Status for NUVARING
Clinical Trial Phase	Trials
Completed	17
Unknown status	4
Terminated	3

Clinical Trial Sponsors for NUVARING

Sponsor Name

Sponsor Name for NUVARING
Sponsor	Trials
Merck Sharp & Dohme Corp.	8
Organon	4
National Institute of Allergy and Infectious Diseases (NIAID)	2

Sponsor Type

Sponsor Type for NUVARING
Sponsor	Trials
Other	26
Industry	17
NIH	3